Bigul

SMS Lifesciences India Ltd - 540679 - Clarification sought from SMS Lifesciences India Ltd

The Exchange has sought clarification from SMS Lifesciences India Ltd on June 12, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
12-06-2020
Bigul

SMS Lifesciences India Ltd - 540679 - IMPACT OF THE COVID-19 PANDEMIC

Information as per SEBI Circular No. SEBI/HO/CFD/CMDI/CIR/P /2020/84 dated May 20, 2020
02-06-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Compliances Not Applicable To The Company.

Provision of "LARGE CORPORATE" and "STATEMENT FOR DEVIATION OR VARIATION" are applicable to the Company as on March 31, 2020
26-05-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Annual Disclosure Of Encumbrance Of Shares By Promoter

Disclosure as per Regulation 31 (4) and (5) of SEBI (SAST) Regulation, 2011
26-05-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Compliance Under Regulation 40(10).

Compliance Certificate for the period from October 01,2019 to March 31. 2020 issued by CSB Associates, Practicing Company Secretary.
11-05-2020
Bigul

SMS Lifesciences India Ltd - 540679 - RTA Compliance Certificate For Q4-F20

RTA Compliance Certificate for Q4-F20
28-04-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2020.
27-04-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Shareholding for the Period Ended March 31, 2020

SMS Lifesciences India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
23-04-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Statement Of Investor Complaints For The Quarter Ended March 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Trupti Ranjan MohantyDesignation :- Company Secretary and Compliance Officer
22-04-2020
Bigul

SMS Lifesciences India Ltd - 540679 - Clarification

With reference to Movement in Price, SMS Lifesciences India Ltd has submitted to BSE a copy of Clarification is enclosed.
17-04-2020
Next Page
Close

Let's Open Free Demat Account